[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 01, 2008

An Ethical View of the Ranibizumab and Bevacizumab Controversy

Arch Ophthalmol. 2008;126(2):286-287. doi:10.1001/archophthalmol.2007.41

The articles by Miller1 and Narayanan and Kupperman2 in the July 2006 issue of the Archives discussed some of the ethically complex issues that relate to randomized clinical trials (RCTs) and off-label use of drugs. We would like to heighten the readers' awareness of a few of the ethical concerns that are critical to understanding the depth of the conundrums that face those involved in clinical practice and research.

First Page Preview View Large
First page PDF preview
First page PDF preview
×